Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.440 | 3.440 | 0.000 |
Stocks | 96.560 | 96.560 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.709 | 17.506 |
Price to Book | 4.654 | 2.767 |
Price to Sales | 2.999 | 2.023 |
Price to Cash Flow | 15.036 | 10.677 |
Dividend Yield | 1.518 | 2.526 |
5 Years Earnings Growth | 13.760 | 11.838 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 34.130 | 14.841 |
Technology | 19.240 | 21.553 |
Consumer Cyclical | 16.930 | 12.560 |
Industrials | 13.770 | 14.344 |
Consumer Defensive | 9.440 | 9.695 |
Basic Materials | 6.480 | 9.555 |
Number of long holdings: 38
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk A/S Class B | DK0060534915 | 8.33 | - | - | |
ASML Holding | NL0010273215 | 7.71 | 858.80 | +3.22% | |
EssilorLuxottica | FR0000121667 | 6.57 | 203.30 | +0.84% | |
Louis Vuitton | FR0000121014 | 5.88 | 792.20 | +1.83% | |
Accenture | IE00B4BNMY34 | 4.60 | 307.93 | -0.35% | |
Linde PLC | IE00BZ12WP82 | 4.29 | - | - | |
Alcon | CH0432492467 | 3.91 | 72.00 | +0.61% | |
Experian | GB00B19NLV48 | 3.69 | 3,272.0 | +1.46% | |
Straumann Holding AG | CH1175448666 | 3.58 | 138.10 | +3.41% | |
Jeronimo Martins | PTJMT0AE0001 | 3.24 | 19.03 | +2.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World USD Acc | 1.01B | 7.65 | 3.58 | 9.01 | ||
Emerging Markets USD Acc | 656.47M | -1.82 | -13.07 | -0.21 | ||
Emerging Markets USD Dis | 656.47M | -0.38 | -11.92 | -0.34 | ||
Asia USD Acc | 175.18M | 1.47 | -11.64 | 5.03 | ||
India USD Acc | 93.09M | 2.57 | 7.85 | 9.63 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review